Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Outcomes of Pulmonary Embolism In Surgical Patients: A Retrospective Cohort Study

Gauruv Bose, Esteban Gandara, Marc Carrier, MD, MSc, Petra Erkens, MG, Marc Rodger, Philip Wells, MD, FRCPC, MSc

Blood (2010) 116 (21): 3180.

https://doi.org/10.1182/blood.V116.21.3180.3180

Published: 2010

Journal Articles

Outcome of Saddle Pulmonary Embolism: A Nested Case-Control Study.

Gauruv Bose, Esteban Gandara, Marc Carrier, MD, MSc, Petra MG Erkens, Marc Rodger, Philip Wells, MD, FRCPC, MSc

Blood (2010) 116 (21): 1102.

https://doi.org/10.1182/blood.V116.21.1102.1102

Published: 2010

Journal Articles

Patients with Cancer Who Develop a First Venous Thromboembolic Event After Surgery Are at High Risk of Venous Thromboembolism Recurrence During the Anticoagulation Period

Martha L Louzada, BSc, MD, Alejandro Lazo-Langner, MD, MSC, Marc Carrier, MD, MSc, Vi Dao, MD, Jerry Zhang, MD, Marc A. Rodger, MD, FRCPC, Michael J. Kovacs, MD, FRCPC, Philip Wells, MD, FRCPC, MSc

Blood (2010) 116 (21): 4202.

https://doi.org/10.1182/blood.V116.21.4202.4202

Published: 2010

Journal Articles

Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Martha L Louzada, BSc, MD, Marc Carrier, MD, MSc, Alejandro Lazo-Langner, MD, MSC, Vi Dao, MD, Jerry Zhang, MD, Michael J. Kovacs, MD, FRCPC, Agnes Y. Lee, MD, MSc, Mark N. Levine, MD, MSC, Guy Meyer, MD, Marc Rodger, Philip Wells, MD, FRCPC, MSc

Blood (2010) 116 (21): 4209.

https://doi.org/10.1182/blood.V116.21.4209.4209

Published: 2010

Journal Articles

Case Fatality Rates of Recurrent Venous Thromboembolism during and Following Anticoagulation Therapy

Marc Carrier, MD, Gregoire Le Gal, MD, PhD, Philip Wells, MD, MSc, Marc Rodger, MD, MSc

Blood (2008) 112 (11): 3032.

https://doi.org/10.1182/blood.V112.11.3032.3032

Published: 2008

Journal Articles

Dose Escalation of Low Molecular Weight Heparin to Manage VTE Treatment Failure in Cancer Patients

Marc Carrier, MD, Gregoire Le Gal, MD, PhD, Sarah Tierney, BSc, Kimberley Do, Philip Wells, MD, FRCPC, MSc, Marc A. Rodger, MD, MSc

Blood (2008) 112 (11): 4050.

https://doi.org/10.1182/blood.V112.11.4050.4050

Published: 2008

Journal Articles

Practical Application of the 10 Mg Warfarin Initiation Nomogram

Philip Wells, MD, FRCPC, MSc, Gregoire Le Gal, MD, PhD, Sarah Tierney, BSc, Marc Carrier, MD

Blood (2008) 112 (11): 4054.

https://doi.org/10.1182/blood.V112.11.4054.4054

Published: 2008

Journal Articles

Trousseau’s Syndrome Revisited: Should We Screen Extensively for Malignancy in Patients with Venous Thromboembolism? a Systematic Review and Meta-Analysis

Marc Carrier, MD, Gregoire Le Gal, MD, PhD, Philip Wells, MD, FRCPC, MSc, Dean Fergusson, PhD, Tim Ramsay, PhD, Marc A Rodger, MD, MSc

Blood (2008) 112 (11): 403.

https://doi.org/10.1182/blood.V112.11.403.403

Published: 2008

Journal Articles

Cost-Effectiveness of Rivaroxaban as VTE Prophylaxis after Total Hip Replacement in Canada.

Philip Wells, MD, FRCPC, MSc, Alexander Diamantopoulos, Fiona Forster, Michael Lees, Heather McDonald

Blood (2008) 112 (11): 1291.

https://doi.org/10.1182/blood.V112.11.1291.1291

Published: 2008

Journal Articles

Indirect Comparisons of Rivaroxaban Versus Alternative Prophylaxes for the Prevention of VTE in Patients Undergoing Total Knee Replacement.

Alexander Diamantopoulos, Corrine LeReun, Farhat Rasul, Michael Lees, Maria Kubin, Philip Wells, MD, FRCPC, MSc

Blood (2008) 112 (11): 1292.

https://doi.org/10.1182/blood.V112.11.1292.1292

Published: 2008

Journal Articles

VIDAS D-Dimer in Combination with Clinical Pre-Test Probability to Rule out Pulmonary Embolism. A Systematic Review of the Management Outcome Studies.

Marc Carrier, MD, Marc Righini, MD, Reza Karami Djurabi, Menno Huisman, Arnaud Perrier, MD, Philip Wells, MD, FRCPC, MSc, Walter Wuillemin, Gregoire Le Gal, MD, PhD

Blood (2008) 112 (11): 1811.

https://doi.org/10.1182/blood.V112.11.1811.1811

Published: 2008

Journal Articles

Alignment to ACCP Prophylaxis Guidelines and VTE Outcomes in THR and TKR Patients

Bijan Borah, PhD, Heather McDonald, MSc, Joe Henk, PhD, Mark A. Crowther, MD, Rita Selby, MD, Philip Wells, MD, FRCPC, MSc

Blood (2008) 112 (11): 170.

https://doi.org/10.1182/blood.V112.11.170.170

Published: 2008

Journal Articles

Increased Incidence of Venous Thromboembolism Following Allogeneic Compared with Autologous Hematopoietic Stem Cell Transplantation.

Andrew Gonsalves, Marc Carrier, MD, Philip Wells, MD, Sheryl McDiarmid, RN, Lothar Huebsch, MD, David Allan, MD

Blood (2007) 110 (11): 3986.

https://doi.org/10.1182/blood.V110.11.3986.3986

Published: 2007

Journal Articles

Current Models for Predicting Warfarin Maintenance Dose Do Not Work in an Ambulatory Venous Thromboembolism Patient Population.

Philip Wells, MD, Marc Rodger, Jennifer Fleming, Sarah Kassem

Blood (2007) 110 (11): 302.

https://doi.org/10.1182/blood.V110.11.302.302

Published: 2007

Journal Articles

The Effect of Dalteparin on Coagulation Activation during Pregnancy in Women with Thrombophilia: A Randomised Trial.

Karim Abou-Nassar, MD, Marc Rodger, MD, Michael J. Kovacs, MD, Steve Doucette, MSc, Ramsay Tim, PhD, Susan Kahn, MD, Philip Wells, MD, Katherine Sue Robinson, MD, Mark Blostein, MD, Susan Solymoss, MD, Evelyne Rey, MD

Blood (2006) 108 (11): 874.

https://doi.org/10.1182/blood.V108.11.874.874

Published: 2006

NARROW

Outcomes of Pulmonary Embolism In Surgical Patients: A Retrospective Cohort Study

Outcome of Saddle Pulmonary Embolism: A Nested Case-Control Study.

Patients with Cancer Who Develop a First Venous Thromboembolic Event After Surgery Are at High Risk of Venous Thromboembolism Recurrence During the Anticoagulation Period

Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Case Fatality Rates of Recurrent Venous Thromboembolism during and Following Anticoagulation Therapy

Dose Escalation of Low Molecular Weight Heparin to Manage VTE Treatment Failure in Cancer Patients

Practical Application of the 10 Mg Warfarin Initiation Nomogram

Trousseau’s Syndrome Revisited: Should We Screen Extensively for Malignancy in Patients with Venous Thromboembolism? a Systematic Review and Meta-Analysis

Cost-Effectiveness of Rivaroxaban as VTE Prophylaxis after Total Hip Replacement in Canada.

Indirect Comparisons of Rivaroxaban Versus Alternative Prophylaxes for the Prevention of VTE in Patients Undergoing Total Knee Replacement.

VIDAS D-Dimer in Combination with Clinical Pre-Test Probability to Rule out Pulmonary Embolism. A Systematic Review of the Management Outcome Studies.

Alignment to ACCP Prophylaxis Guidelines and VTE Outcomes in THR and TKR Patients

Increased Incidence of Venous Thromboembolism Following Allogeneic Compared with Autologous Hematopoietic Stem Cell Transplantation.

Current Models for Predicting Warfarin Maintenance Dose Do Not Work in an Ambulatory Venous Thromboembolism Patient Population.

The Effect of Dalteparin on Coagulation Activation during Pregnancy in Women with Thrombophilia: A Randomised Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only